Other Species / Isoforms
  Srcasm (mouse)      LTP 

LTP (Low Throughput Papers) : The number of records in which this modification site was determined using methods other than discovery mass spectrometry.

 HTP 

HTP (High Throughput Papers): The number of records in which this modification site was assigned using ONLY proteomic discovery mass spectrometry.

 
K5-ub
___MAFGkSHRDPYA
0 4
Srcasm (human) ___MAFGksHRDPyA K5-ub
Srcasm (mouse) ___MAFGkSHRDPYA K5-ub
Srcasm (rat) ___MAFGKSHRDPYA K5
S6
__MAFGkSHRDPYAT
0 1
Srcasm (human) __MAFGksHRDPyAT S6-p
Srcasm (mouse) __MAFGkSHRDPYAT S6
Srcasm (rat) __MAFGKSHRDPYAT S6
Y11
GkSHRDPYATSVGHL
0 7
Srcasm (human) GksHRDPyATSVGHL Y11-p
Srcasm (mouse) GkSHRDPYATSVGHL Y11
Srcasm (rat) GKSHRDPYATSLGHL Y11
K93
SFQSLIVKKEFIKDT
0 1
Srcasm (human) SFQSLIVkKEFVkEN K93-ac
Srcasm (mouse) SFQSLIVKKEFIKDT K93
Srcasm (rat) SFQSLIVKKEFVKDT K93
K98
IVKKEFIKDTLVKLL
0 1
Srcasm (human) IVkKEFVkENLVkLL K98-ub
Srcasm (mouse) IVKKEFIKDTLVKLL K98
Srcasm (rat) IVKKEFVKDTLVKLL K98
K103
FIKDTLVKLLNPRYT
0 1
Srcasm (human) FVkENLVkLLNPRyN K103-ub
Srcasm (mouse) FIKDTLVKLLNPRYT K103
Srcasm (rat) FVKDTLVKLLNPRYT K103
Y109
VKLLNPRYTLPLETQ
0 4
Srcasm (human) VkLLNPRyNLPLDIQ Y109-p
Srcasm (mouse) VKLLNPRYTLPLETQ Y109
Srcasm (rat) VKLLNPRYTLPLETQ Y109
K148-ub
EVYLDLLkKGVQFPP
0 5
Srcasm (human) EVYLDLVkkGVQFPP K148-ub
Srcasm (mouse) EVYLDLLkKGVQFPP K148-ub
Srcasm (rat) EVYLDLLKKGVQFPP K148
K149
VYLDLLkKGVQFPPS
0 1
Srcasm (human) VYLDLVkkGVQFPPS K149-ub
Srcasm (mouse) VYLDLLkKGVQFPPS K149
Srcasm (rat) VYLDLLKKGVQFPPL K149
S170-p
RQEAGQIsPNRPtsV
0 5
Srcasm (human) RQETAQISSNPPTSV S171
Srcasm (mouse) RQEAGQIsPNRPtsV S170-p
Srcasm (rat) KQEAGQIsPSRPTSV S170-p
T175-p
QIsPNRPtsVPTAPA
0 1
Srcasm (human) QISSNPPTSVPTAPA T176
Srcasm (mouse) QIsPNRPtsVPTAPA T175-p
Srcasm (rat) QIsPSRPTSVPTAPA T175
S176-p
IsPNRPtsVPTAPAL
0 1
Srcasm (human) ISSNPPTSVPTAPAL S177
Srcasm (mouse) IsPNRPtsVPTAPAL S176-p
Srcasm (rat) IsPSRPTSVPTAPAL S176
K190-ub
LSSIIAPkNPTISLV
0 5
Srcasm (human) LSSVIAPkNSTVTLV K191-ub
Srcasm (mouse) LSSIIAPkNPTISLV K190-ub
Srcasm (rat) LSSIIAPKNPTISLV K190
S206
EQIGKLHSELDMVKM
0 1
Srcasm (human) EQIGKLHsELDMVKM S207-p
Srcasm (mouse) EQIGKLHSELDMVKM S206
Srcasm (rat) EQIGKLHSELDMVKM S206
K240
EDIELLRKLYKTGRE
0 1
Srcasm (human) EDIELLQkLYKTGRE K241-ub
Srcasm (mouse) EDIELLRKLYKTGRE K240
Srcasm (rat) EDIELLRKLYKTGRE K240
R297
QRLLEQKRNRTEATR
0 4
Srcasm (human) QRILEQNkNQkEATN K298-ub
Srcasm (mouse) QRLLEQKRNRTEATR R297
Srcasm (rat) QRLLEQKRNPTEANQ R297
R297
QRLLEQKRNRTEATR
0 1
Srcasm (human) QRILEQNkNQkEATN K298-m2
Srcasm (mouse) QRLLEQKRNRTEATR R297
Srcasm (rat) QRLLEQKRNPTEANQ R297
T300
LEQKRNRTEATRTSS
0 4
Srcasm (human) LEQNkNQkEATNTTS K301-ub
Srcasm (mouse) LEQKRNRTEATRTSS T300
Srcasm (rat) LEQKRNPTEANQTSS T300
S310
TRTSSEPSAPSCDLL
0 2
Srcasm (human) TNTTSEPsAPsQDLL S311-p
Srcasm (mouse) TRTSSEPSAPSCDLL S310
Srcasm (rat) NQTSSEPSAPSCDLL S310
S313
SSEPSAPSCDLLDLs
0 1
Srcasm (human) TSEPsAPsQDLLDLs S314-p
Srcasm (mouse) SSEPSAPSCDLLDLs S313
Srcasm (rat) SSEPSAPSCDLLNLG S313
S320-p
SCDLLDLsPIVPVPT
Upstream
Downstream
1 14
Effects on Modified Protein
  • molecular association, regulation
Treatment
  • lapatinib
Srcasm (human) sQDLLDLsPsPRMPR S321-p
Srcasm (mouse) SCDLLDLsPIVPVPT S320-p
Srcasm (rat) SCDLLNLGPVAPVPV G320
I322
DLLDLsPIVPVPTPN
0 28
Srcasm (human) DLLDLsPsPRMPRAT S323-p
Srcasm (mouse) DLLDLsPIVPVPTPN I322
Srcasm (rat) DLLNLGPVAPVPVSS V322
S341
NSVNAQLSGLSVSSL
0 1
Srcasm (human) NTMNNQLsGLNFSLP S342-p
Srcasm (mouse) NSVNAQLSGLSVSSL S341
Srcasm (rat) NSVNAQLSGLNVSSQ S341
Y392-p
NLASSHTyDNFHSNS
Upstream
Downstream
3 1
Effects on Modified Protein
  • molecular association, regulation
Effects on Biological Processes:
  • cell growth, altered
Putative in vivo kinases:
  • Fyn (mouse)
Treatment
  • EGF
Srcasm (human) NLTSSHAyDNFLEHS Y392-p
Srcasm (mouse) NLASSHTyDNFHSNS Y392-p
Srcasm (rat) NLASSHTYDNFPDHS Y392
Y440-p
GDLQPPNyyEVMEFD
Upstream
Downstream
2 4
Effects on Modified Protein
  • molecular association, regulation
Effects on Biological Processes:
  • cell growth, altered
Putative in vivo kinases:
  • Fyn (mouse)
Treatment
  • EGF
Srcasm (human) SDLQPPNyyEVMEFD Y441-p
Srcasm (mouse) GDLQPPNyyEVMEFD Y440-p
Srcasm (rat) SALQPPSYYEVMEFD Y441
Y441-p
DLQPPNyyEVMEFDP
Upstream
Downstream
2 6
Effects on Modified Protein
  • molecular association, regulation
Effects on Biological Processes:
  • cell growth, altered
Putative in vivo kinases:
  • Fyn (mouse)
Treatment
  • EGF
Srcasm (human) DLQPPNyyEVMEFDP Y442-p
Srcasm (mouse) DLQPPNyyEVMEFDP Y441-p
Srcasm (rat) ALQPPSYYEVMEFDP Y442
T452
EFDPLAPTTEAVyEE
0 5
Srcasm (human) DPLAPAVttEAIyEE T455-p
Srcasm (mouse) EFDPLAPTTEAVyEE T452
Srcasm (rat) EFDPLAPTTEAIYEE T453
T453
FDPLAPTTEAVyEEI
0 2
Srcasm (human) PLAPAVttEAIyEEI T456-p
Srcasm (mouse) FDPLAPTTEAVyEEI T453
Srcasm (rat) FDPLAPTTEAIYEEI T454
Y457-p
APTTEAVyEEIDGYH
Upstream
Downstream
4 37
Effects on Modified Protein
  • molecular association, regulation
Effects on Biological Processes:
  • cell growth, altered
Putative in vivo kinases:
  • Fyn (mouse)
Treatment
  • EGF
Srcasm (human) AVttEAIyEEIDAHQ Y460-p
Srcasm (mouse) APTTEAVyEEIDGYH Y457-p
Srcasm (rat) APTTEAIYEEIDASH Y458